1,861
Views
14
CrossRef citations to date
0
Altmetric
Research Papers

Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine

, , , , &
Pages 1046-1056 | Received 21 Oct 2014, Accepted 09 Jan 2015, Published online: 01 May 2015

References

  • Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3:757-71; PMID:14652202; http://dx.doi.org/10.1016/S1473-3099(03)00830-2
  • Levett PN. Leptospirosis: a forgotten zoonosis? Clin App Immunol Rev 2004; 4:435-48; http://dx.doi.org/10.1016/j.cair.2004.08.001
  • Yanagihara Y, Villanueva SYAM, Yoshida SI, Okamoto Y, Masuzawa T. Current status of leptospirosis in Japan and Philippines. Comp Immunol Microbiol Infect Dis 2007; 30:399-413; PMID:17614131; http://dx.doi.org/10.1016/j.cimid.2007.05.003
  • Victoriano A, Smythe L, Gloriani-Barzaga N, Cavinta L, Kasai T, Limpakarnjanarat K, Ong B, Gongal G, Hall J, Coulombe C, et al. Leptospirosis in the Asia Pacific region. BMC Infect Dis 2009; 9:147; PMID:19732423; http://dx.doi.org/10.1186/1471-2334-9-147
  • Balbuena A, Herbosa T, Gundran C. Cases of leptospirosis after typhoon Ondoy (international name: Ketsana) seen at the emergency department: the philippine general hospital experience. WIT Trans Inform Commu Tech 2010; 43:PI-605-612.
  • Borja M. Burden of Disease Study: Leptospirosis in an Urban Setting, Metro Manila. Manila 2012. Available at http://cph.upm.edu.ph/?q=node/337. Accessed on 14 July 2013
  • Laurichesse H, Gourdon F, Smits HL, Abdoe TH, Estavoyer JM, Rebika H, Pouliquen P, Catalina P, Dubray C, Beytout J. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers. Clin Microbiol Infect 2007; 13:395-403; PMID:17359323; http://dx.doi.org/10.1111/j.1469-0691.2007.01662.x
  • Martínez R, Pérez A, Quiñones MdC, Cruz R, Álvarez Á, Armesto M, Fernández C, Menéndez J, Rodríguez I, Baró M, et al. Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba. Rev Panam Salud Pública 2004; 15:249-55; PMID:15193180
  • González M, Martínez R, Paz RCdl, Bourzac JFI, Novo IG, Suárez MB, Sierra AP, González GS, Rodríguez OF, Gutiérrez RB, et al. vax-Spiral®. Trivalent antileptospirosis vaccine for human use: research, development and impact on the disease in Cuba. MEDICC Rev 2004; 2:33.
  • Watanabe H, Koizumi N. Leptospirosis vaccines: past, present, and future. J Postgrad Med 2005; 51:210-4; PMID:16333195
  • Mould Quevedo JF, Contreras Hernández I, Garduño Espinosa J, Salinas Escudero G. The willingness-to-pay concept in question. Rev Saúde Pública 2009; 43:352-8; PMID:19225694; http://dx.doi.org/10.1590/S0034-89102009005000007
  • Breidert C, Hahsler M, Reutterer T. A review of methods for measuring willingness-to-pay. Innovat Market 2006; 2:8-32
  • Mangham LJ, Hanson K, McPake B. How to do (or not to do) … Designing a discrete choice experiment for application in a low-income country. Health Policy Plan 2009; 24:151-8; PMID:19112071; http://dx.doi.org/10.1093/heapol/czn047
  • Ryan M, Bate A, Eastmond C, Ludbrook A. Use of discrete choice experiments to elicit preferences. Quality Health Care 2001; 10:i55-i60; PMID:11533440; http://dx.doi.org/10.1136/qhc.0100055
  • Hall J, Kenny P, King M, Louviere J, Viney R, Yeoh A. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ 2002; 11:457-65; PMID:12112494; http://dx.doi.org/10.1002/hec.694
  • de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, Raat H, Korfage IJ. Girls’ preferences for HPV vaccination: a discrete choice experiment. Vaccine 2010; 28:6692-7; PMID:20708696; http://dx.doi.org/10.1016/j.vaccine.2010.08.001
  • Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sex Trans Infect 2011; 87:52-7; PMID:20956352; http://dx.doi.org/10.1136/sti.2009.041392
  • Cameron MP, Newman PA, Roungprakhon S, Scarpa R. The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine 2013; 31:3712-7; PMID:23747452; http://dx.doi.org/10.1016/j.vaccine.2013.05.089
  • Weaver J, Newman PA, Williams CC, Massaquoi N, Brown M. “Sisters, mothers, daughters and aunties”: HIV vaccine acceptability among African, caribbean and other black women in Toronto. Can J Public Health 2013; 104:e413-e7; PMID:24183184
  • Hensher DA, Rose JM, Greene WH. Applied choice analysis: a primer. Cambridge University Press; 2005; 744.
  • Hofman R, de Bekker-Grob EW, Raat H, Helmerhorst TJ, van Ballegooijen M, Korfage IJ. Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment. BMC Public Health 2014; 14:454; PMID:24885861; http://dx.doi.org/10.1186/1471-2458-14-454
  • Opel DJ, Diekema DS, Lee NR, Marcuse EK. Social marketing as a strategy to increase immunization rates. Arch Pediatr Adolesc Med 2009; 163:432-7; PMID:19414689; http://dx.doi.org/10.1001/archpediatrics.2009.42
  • CDC. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morbidity and mortality weekly report: Centers for Disease Control Prevention, 2013:591.
  • Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the costa rica vaccine trial. Cancer Prevention Res 2013; 6:1242-50; PMID:24189371; http://dx.doi.org/10.1158/1940-6207.CAPR-13-0203
  • Pennie RA, O'Connor AM, Dulberg CS, Bottiglia A, Manga P, Kang CY. Low-cost hepatitis B vaccine improves uptake among self-paying health-care students. J Med Virol 1992; 37:48-53; PMID:1535653; http://dx.doi.org/10.1002/jmv.1890370108
  • Wilson P, Jones A. Giving developing countries the best shot: an overview of vaccine access and R & D. Oxfam International 2010; 28.
  • Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, Lewis-Bell K, Lewis MJ, Penny ME. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine 2008; 26:L73-L9; PMID:18945404; http://dx.doi.org/10.1016/j.vaccine.2008.05.027
  • Andrus JK, Sherris J, Fitzsimmons JW, Kane MA, Aguado MT. Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement. Vaccine 2008; 26(Supplement 10):K87-K92; PMID:18847561; http://dx.doi.org/10.1016/j.vaccine.2008.05.003
  • PHILHEALTH. Leptospirosis Benefit Package. 2012. Available at http://www.philhealth.gov.ph/circulars/2012/circ40_2012.pdf. Acessed on August 24,2014.
  • Marshall H, Ryan P, Roberton D, Baghurst P. A cross-sectional survey to assess community attitudes to introduction of Human Papillomavirus vaccine. Aust N Z J Public Health 2007; 31:235-42; PMID:17679241; http://dx.doi.org/10.1111/j.1467-842X.2007.00054.x
  • Ibuka Y, Chapman G, Meyers L, Li M, Galvani A. The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis 2009; 10:296; http://dx.doi.org/10.1186/1471-2334-10-296
  • Ignacio V-S, Cardenas-Marrufo MF, Jimenez-Delgadillo B, Alzina-Lopez A, Laviada-Molina H, Suarez-Solis V, Zavala-Velazquez JE. Clinical-epidemiological study of leptospirosis in humans and reservoirs in Yucatan, Mexico. Rev Inst Med Trop Sao Paulo 2002; 44:335-40; PMID:12532218
  • Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother 2001; 7:59-68; PMID:11455495; http://dx.doi.org/10.1007/s101560100011
  • Fletcher JM, Frisvold DE. Higher education and health investments: does more schooling affect preventive health care use? J Hum Cap 2009; 3:144; PMID:22368727; http://dx.doi.org/10.1086/645090
  • Scott TL, Gazmararian JA, Williams MV, Baker DW. Health literacy and preventive health care use among Medicare enrollees in a managed care organization. Med Care 2002; 40:395-404; PMID:11961474; http://dx.doi.org/10.1097/00005650-200205000-00005
  • Rosenzweig MR, Schultz TP. Schooling, information and nonmarket productivity: contraceptive use and its effectiveness. Int Econ Rev 1989: 30:457-77; http://dx.doi.org/10.2307/2526657
  • Grossman M. Education and nonmarket outcomes. Handbook Econo Educat 2006; 1:577-633; http://dx.doi.org/10.1016/S1574-0692(06)01010-5
  • Dias JP, Teixeira MG, Costa MCN, Mendes CMC, Guimarães P, Reis MG, Ko A, Barreto ML. Factors associated with Leptospira sp infection in a large urban center in northeastern Brazil. Rev Soc Bras Med Trop 2007; 40:499-504; PMID:17992402; http://dx.doi.org/10.1590/S0037-86822007000500002
  • Ndiritu M, Cowgill K, Ismail A, Chiphatsi S, Kamau T, Fegan G, Feikin D, Newton C, Scott JA. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health 2006; 6:132; PMID:16707013; http://dx.doi.org/10.1186/1471-2458-6-132
  • Pavlopoulou I, Michail K, Samoli E, Tsiftis G, Tsoumakas K. Immunization coverage and predictive factors for complete and age-appropriate vaccination among preschoolers in Athens, Greece: a cross- sectional study. BMC Public Health 2013; 13:908; PMID:24083352; http://dx.doi.org/10.1186/1471-2458-13-908
  • Maciel EAP, de Carvalho ALF, Nascimento SF, de Matos RB, Gouveia EL, Reis MG, Ko AI. Household Transmission of Leptospira Infection in Urban Slum Communities. PLoS Negl Trop Dis 2008; 2:e154; PMID:18357340; http://dx.doi.org/10.1371/journal.pntd.0000154
  • Reis RB, Ribeiro GS, Felzemburgh RDM, Santana FS, Mohr S, Melendez AXTO, Queiroz A, Santos AC, Ravines RR, Tassinari WS, et al. Impact of Environment and Social Gradient on Leptospira Infection in Urban Slums. PLoS Negl Trop Dis 2008; 2:e228; PMID:18431445; http://dx.doi.org/10.1371/journal.pntd.0000228
  • Easton A. Leptospirosis in Philippine floods. BMJ 1999; 319:212; PMID:10417074; http://dx.doi.org/10.1136/bmj.319.7202.75c
  • Gaynor K, Katz AR, Park SY, Nakata M, Clark TA, Effler PV. Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg 2007; 76:882-6; PMID:17488909
  • Kawaguchi L, Sengkeopraseuth B, Tsuyuoka R, Koizumi N, Akashi H, Vongphrachanh P, Watanabe H, Aoyama A. Seroprevalence of leptospirosis and risk factor analysis in flood-prone rural areas in Lao PDR. Am J Trop Med Hyg 2008; 78:957-61; PMID:18541776
  • De A, Varaiya A, Mathur M, Bhat M, Karande S, Yeolekar M. An outbreak of leptospirosis in Mumbai. Indian J Med Microbiol 2002; 20:153; PMID:17657056
  • Arbiol J, Borja M, Yabe M, Nomura H, Gloriani N, Yoshida S-I. Valuing human leptospirosis prevention using the opportunity cost of labor. Int J Environ Res Public Health 2013; 10:1845-60; PMID:23644831; http://dx.doi.org/10.3390/ijerph10051845
  • Unger A, Riley LW. Slum health: from understanding to action. PLoS Med 2007; 4:e295; PMID:17958462; http://dx.doi.org/10.1371/journal.pmed.0040295
  • Ballesteros MM. Linking poverty and the environment: evidence from slums in Philippine cities. PIDS Discussion Paper Series. Makati City: Philippine Instituture for Development Studies; 2010.
  • Hadisoemarto PF, Castro MC. Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in bandung, indonesia. PLoS Negl Trop Dis 2013; 7:e2427; PMID:24069482; http://dx.doi.org/10.1371/journal.pntd.0002427
  • Al-shere TA, Ujiie M, Suzuki M, Salva E, Belo MCP, Koizumi N, Yoshimatsu K, Schmidt W-P, Marte S, Dimaano EM. Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis 2012; 18:91; PMID:22257492; http://dx.doi.org/10.3201/eid1801.101892
  • Verma R, Khanna P, Chawla S. Whole-cell inactivated Leptospirosis vaccine: future prospects. Hu Vaccin Immunother 2013; 9:763; PMID:23295984; http://dx.doi.org/10.4161/hv.23059
  • Dellagostin OA, Grassmann AA, Hartwig DD, Félix SR, da Silva ÉF, McBride AJ. Recombinant vaccines against leptospirosis. Hum Vaccin 2011; 7:1215-24; PMID:22048111; http://dx.doi.org/10.4161/hv.7.11.17944
  • Wang Z, Jin L, Węgrzyn A. Leptospirosis vaccines. Microb Cell Fact 2007; 6:39; PMID:18072968; http://dx.doi.org/10.1186/1475-2859-6-39
  • Fernández LAR, Santiesteban NB, Arencibia DF, Arrebola BYVA, Toruño WJ, Duttman C. Efficacy of Leptospiral vaccine (vax-SPIRAL) against challenge with strains isolated from leptospirosis epidemic in Nicaragua using the hamster as biomodel. Veter World 2012; 5:5-12; http://dx.doi.org/10.5455/vetworld.2012.5-12
  • Chen T. Development and present status of a leptospiral vaccine and the technology of vaccine production in China. Nihon Saikingaku Zasshi 1985; 40:755-62; PMID:3903244; http://dx.doi.org/10.3412/jsb.40.755
  • Rathinam S. Ocular leptospirosis. Curr Opin Ophthalmol 2002; 13:381-6; PMID:12441841; http://dx.doi.org/10.1097/00055735-200212000-00007
  • Taguchi G. Tables of orthogonal arrays and linear graphs. Tokyo: Maruzen; 1962.
  • Street DJ, Burgess L, Louviere JJ. Quick and easy choice sets: constructing optimal and nearly optimal stated choice experiments. Int J Res Market 2005; 22:459-70; http://dx.doi.org/10.1016/j.ijresmar.2005.09.003
  • Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge University Press; 2000; 402.
  • Revelt D, Train K. Mixed logit with repeated choices: households' choices of appliance efficiency level. Rev Econ Stat 1998; 80:647-57; http://dx.doi.org/10.1162/003465398557735
  • Kontoleon A, Yabe M. Assessing the impacts of alternative'Opt-out'formats in choice experiment studies: consumer preferences for genetically modified content and production information in food. J Agri Policy Res (Japan) 2003:1-43
  • Train KE. Recreation demand models with taste differences over people. Land Econ 1998:230-39; http://dx.doi.org/10.2307/3147053
  • Olynk NJ, Tonsor GT, Wolf CA. Consumer willingness to pay for livestock credence attribute claim verification. J Agri Res Econo 2010:261-80
  • ESI. NLOGIT-4. New York ,USA: Econometric Software, Inc; 2007.
  • Swait J, Louviere J. The role of the scale parameter in the estimation and comparison of multinomial logit models. J Market Res 1993:305-14; http://dx.doi.org/10.2307/3172883
  • Morrison M, Bennett J, Blamey R. Valuing improved wetland quality using choice modeling. Water Reso Res 1999; 35:2805-14; http://dx.doi.org/10.1029/1999WR900020
  • Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002; 37:1681-705; PMID:12546292; http://dx.doi.org/10.1111/1475-6773.01115
  • Scott A, Witt J, Humphreys J, Joyce C, Kalb G, Jeon S-H, McGrail M. Melbourne Institute Working Paper Series. 2012.
  • Boxall PC, Adamowicz WL, Swait J, Williams M, Louviere J. A comparison of stated preference methods for environmental valuation. Ecol Econo 1996; 18:243-53; http://dx.doi.org/10.1016/0921-8009(96)00039-0

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.